Skip to content
10-Q

Quarterly Report

BIOETHICS, LTD.

0001096906-24-001197

← back to feed
Filed
May 20, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 20, 2024 1.14M sh
Operating Cash Flow Q1 2024 · Mar 31, 2024 −$5.9K
Cash And Equivalents Q1 2024 · Mar 31, 2024 $93
Cash And Equivalents Q1 2024 · Dec 31, 2023 $138
Stockholders Equity Q1 2024 · Mar 31, 2024 −$815.92K
Stockholders Equity Q1 2024 · Dec 31, 2023 −$776.27K
Current Liabilities Q1 2024 · Mar 31, 2024 $816.01K
Current Liabilities Q1 2024 · Dec 31, 2023 $776.4K
Total Liabilities Q1 2024 · Mar 31, 2024 $816.01K
Total Liabilities Q1 2024 · Dec 31, 2023 $776.4K
Current Assets Q1 2024 · Mar 31, 2024 $93
Current Assets Q1 2024 · Dec 31, 2023 $138
Total Assets Q1 2024 · Mar 31, 2024 $93
Total Assets Q1 2024 · Dec 31, 2023 $138
Eps Basic Q1 2024 · Mar 31, 2024 −$0.03
Sga Expense Q1 2024 · Mar 31, 2024 $27.22K
Operating Income Q1 2024 · Mar 31, 2024 −$27.22K
Revenue Q1 2024 · Mar 31, 2024 $0